Back to today’s briefing

Story perspectives

$200M Investment to Revive Woolly Mammoth and More!

2/17/2025

50 7

Summary

Story summary

Colossal Biosciences has secured a groundbreaking $200 million to bring extinct species like the woolly mammoth back to life by 2028. Founder Ben Lamm envisions a world where extinction is a thing of the past, utilizing cutting-edge gene editing. With notable investors like Chelsea co-owner Mark Walter, the company also aims to resurrect the Tasmanian tiger and dodo, promising significant ecological benefits.

1 of 1

Story summary

Colossal Biosciences has secured a groundbreaking $200 million to bring extinct species like the woolly mammoth back to life by 2028. Founder Ben Lamm envisions a world where extinction is a thing of the past, utilizing cutting-edge gene editing. With notable investors like Chelsea co-owner Mark Walter, the company also aims to resurrect the Tasmanian tiger and dodo, promising significant ecological benefits.